Maity A, Das A, Roy R, Malik M, Das S, Paul P
3 Biotech. 2025; 15(4):77.
PMID: 40060287
PMC: 11885756.
DOI: 10.1007/s13205-025-04246-0.
Alwaili M, Abu-Almakarem A, El-Said K, Eid T, Mobasher M, Alsabban A
Sci Rep. 2025; 15(1):8126.
PMID: 40057537
PMC: 11890735.
DOI: 10.1038/s41598-025-90549-4.
Ordonez W, Palomino N, Varela P, Martinez I, Alves L, Giuliatti S
Neurochem Res. 2025; 50(2):116.
PMID: 40056267
PMC: 11890331.
DOI: 10.1007/s11064-025-04354-6.
Noga M, Jurowski K
Arch Toxicol. 2025; .
PMID: 40050428
DOI: 10.1007/s00204-025-04000-8.
Dhawan B, Alam M, Hamid H, Yadav A, Akhter G, Dar M
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40029384
DOI: 10.1007/s00210-025-03853-1.
Molecular screening and dynamics simulation reveal potential phytocompounds in Swertia chirayita targeting the UspA1 protein of Moraxella catarrhalis for COPD therapy.
Uddin M, Chowdhury M, Hossain M, Ahsan A, Hossain M, Barik A
PLoS One. 2025; 20(2):e0316275.
PMID: 40019889
PMC: 11870343.
DOI: 10.1371/journal.pone.0316275.
Network pharmacology to unveil the blood components and mechanisms of Tongmai Yangxin Pills in treating elderly coronary heart disease.
Zhang Y, Li C, Yan Y, Lin J, Zhu S, Tan S
Front Cardiovasc Med. 2025; 12:1475546.
PMID: 40017515
PMC: 11865046.
DOI: 10.3389/fcvm.2025.1475546.
Molecular modeling of the interactions of compounds of against dihydrofolate reductase-thymidylate synthase in towards development of anti-malarial drug.
Chike-Ekwughe A, Abdulameed H, Adebayo-Gege G, Usman A, Omoyungbo E, Ala A
In Silico Pharmacol. 2025; 13(1):31.
PMID: 39990732
PMC: 11839966.
DOI: 10.1007/s40203-025-00317-5.
Comprehensive metabolite profiling and evaluation of anti-nociceptive and anti-inflammatory potencies of (Wurmb.) leaves: Experimental and in-silico approaches.
Islam F, Aktaruzzaman M, Islam M, Rodru F, Yesmine S
Heliyon. 2025; 11(3):e42074.
PMID: 39975840
PMC: 11835622.
DOI: 10.1016/j.heliyon.2025.e42074.
Computational exploration in search for novel natural product-derived EZH2 inhibitors for advancing anti-cancer therapy.
Shyamal S
Mol Divers. 2025; .
PMID: 39969739
DOI: 10.1007/s11030-025-11128-3.
Unveiling ferroptosis genes and inhibitors in diabetic retinopathy through single-cell analysis and docking simulations.
Khan M, Ganguly A, Barman S, Das C, Ganesan S
Biochem Biophys Rep. 2025; 41:101932.
PMID: 39968183
PMC: 11833632.
DOI: 10.1016/j.bbrep.2025.101932.
Targeting beta-lactamase activity with Oxacyclohexadecan-2-one in carbapenem-resistant uropathogenic E. coli: A molecular simulation approach.
Balaji P, N M, Bhaskar M E, R G, Paul S, R M
PLoS One. 2025; 20(2):e0317941.
PMID: 39964973
PMC: 11835335.
DOI: 10.1371/journal.pone.0317941.
Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents.
Du H, Ma F, Cao Y, Bai M, Gao X, Yang Z
Front Chem. 2025; 13:1545908.
PMID: 39944895
PMC: 11813896.
DOI: 10.3389/fchem.2025.1545908.
Chloride and Acetonitrile Ruthenium(IV) Complexes: Crystal Architecture, Chemical Characterization, Antibiofilm Activity, and Bioavailability in Biological Systems.
Jablonska-Wawrzycka A, Rogala P, Czerwonka G, Hodorowicz M, Kalinowska-Tluscik J, Karpiel M
Molecules. 2025; 30(3).
PMID: 39942666
PMC: 11820517.
DOI: 10.3390/molecules30030564.
Computer aided design of inhibitor molecules against Vpr protein from different HIV-1 subtypes.
Datta J, Majumder S, Giri K
In Silico Pharmacol. 2025; 13(1):23.
PMID: 39931696
PMC: 11807045.
DOI: 10.1007/s40203-025-00318-4.
Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: biological and pharmacokinetic assessments.
Ruankham W, Pingaew R, Prachayasittikul V, Worachartcheewan A, Sathuphong S, Apiraksattayakul S
RSC Adv. 2025; 15(6):4281-4295.
PMID: 39931414
PMC: 11809491.
DOI: 10.1039/d4ra04941a.
Deciphering the potential of plant metabolites as insecticides against melon fly (): Exposing control alternatives to assure food security.
Chowdhury Z, Banik A, Robin T, Chowdhury M
Heliyon. 2025; 11(2):e42034.
PMID: 39906852
PMC: 11791130.
DOI: 10.1016/j.heliyon.2025.e42034.
Multi-scale computational modeling to identify novel chemical scaffolds as trehalose-6-phosphate phosphatase inhibitors to combat .
Noor S, Aljasir M, Bashir M, Khan K, Ahmad S, Abideen S
In Silico Pharmacol. 2025; 13(1):21.
PMID: 39901924
PMC: 11787118.
DOI: 10.1007/s40203-025-00309-5.
Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.
Munoz-Ayala A, Garcia-Gonzalez V, Pulido-Capiz A, Chimal-Vega B, Garcia-Villarreal R, Vique-Sanchez J
Int J Mol Cell Med. 2025; 13(4):350-360.
PMID: 39895918
PMC: 11786125.
DOI: 10.22088/IJMCM.BUMS.13.4.350.
Fragment optimized chalcone derivatives targeting OmpA protein as a therapeutic approach against multidrug resistant Acinetobacter baumannii.
Naveed M, Abid A, Aziz T, Saleem A, Arshad A, Javed K
Sci Rep. 2025; 15(1):3917.
PMID: 39890884
PMC: 11785799.
DOI: 10.1038/s41598-025-88191-1.